Oxygen
Identification
- Summary
Oxygen is an essential element for human survival used in clinical conditions in which there is a lack of oxygen, such as, but not limited to, anoxia, hypoxia or dyspnea.
- Brand Names
- Alnox, Ez-OX, Heliox, Oxygen, Southern Medical
- Generic Name
- Oxygen
- DrugBank Accession Number
- DB09140
- Background
Oxygen is an element displayed by the symbol O, and atomic number 8. It is an essential element for human survival. Decreased oxygen levels may be treated with medical oxygen therapy. Treatment with oxygen serves to increase blood oxygen levels and also exerts a secondary effect of decreasing blood flow resistance in the diseased lung, leading to decreased cardiovascular workload in an attempt to oxygenate the lungs. Oxygen therapy is used to treat emphysema, pneumonia, some heart disorders (congestive heart failure), some disorders that cause increased pulmonary artery pressure, and any disease that impairs the body's ability to take up and use gaseous oxygen. Higher level of oxygen than ambient air (hyperoxia) can be introduced under normobaric or hyperbaric conditions.
- Type
- Small Molecule
- Groups
- Approved, Vet approved
- Structure
- Weight
- Average: 31.9988
Monoisotopic: 31.989829244 - Chemical Formula
- O2
- Synonyms
- Dioxygen
- Molecular oxygen
- Oxigeno gaseoso
- Oxygen
- Oxygen USP
- Pure oxygen
- External IDs
- E-948
- INS NO.948
- INS-948
Pharmacology
- Indication
Oxygen therapy in clinical settings is used across diverse specialties, including various types of anoxia, hypoxia or dyspnea and any other disease states and conditions that reduce the efficiency of gas exchange and oxygen consumption such as respiratory illnesses, trauma, poisonings and drug overdoses. Oxygen therapy tries to achieve hyperoxia 6 to reduce the extent of hypoxia-induced tissue damage and malfunction.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Symptomatic treatment of Anemia ••• ••••• ••• Symptomatic treatment of Cancer ••• ••••• ••• Prevention of Hypoxemia •••••••••••• ••• Treatment of Hypoxemia •••••••••••• ••• Symptomatic treatment of Migraines ••• ••••• ••• - Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Oxygen therapy improves effective cellular oxygenation, even at a low rate of tissue perfusion. Oxygen molecules adjust hypoxic ventilatory drive by acting on chemoreceptors on carotid bodies that sequentially relay sensory information to the higher processing centers in brainstem. It also attenuates hypoxia-induced mitochondrial depolarization that generates reactive oxygen species and/or apoptosis. Studies investigating on hyperbaric oxygen therapy has shown that oxygen supplementation can induce neural stem cell proliferation in neonatal rats thus promoting neurological regeneration after injuries 3. CD34+, CD45-dim leukocytes are also potential targets for hyperbaric oxygen therapy benefit as their mobilization was increased in vitro which could facilitate the acceleration of recovery at peripheral sites 1.
- Mechanism of action
Oxygen therapy increases the arterial pressure of oxygen and is effective in improving gas exchange and oxygen delivery to tissues, provided that there are functional alveolar units. Oxygen plays a critical role as an electron acceptor during oxidative phosphorylation in the electron transport chain through activation of cytochrome c oxidase (terminal enzyme of the electron transport chain). This process achieves successful aerobic respiration in organisms to generate ATP molecules as an energy source in many tissues. Oxygen supplementation acts to restore normal cellular activity at the mitochondrial level and reduce metabolic acidosis. There is also evidence that oxygen may interact with O2-sensitive voltage-gated potassium channels in glomus cells and cause hyperpolarization of mitochondrial membrane 4.
Target Actions Organism UCytochrome c oxidase subunit 1 agonistactivatorHumans UNADPH oxidase 1 agonistactivatorHumans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Oxygen binds to oxygen-carrying protein in red blood cells called hemoglobin with high affinity. The amount of oxygen molecules bound to the fixed amount of circulating hemoglobin in the blood determines the overall oxygen saturation level and this oxygen-delivering capacity is regulated by Bohr effect.
- Metabolism
- Not Available
- Route of elimination
Exhalation
- Half-life
Approximately 122.24 seconds
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
May cause burns or frostbites in case of eye or skin contact with rapidly expanding gas. Oxygen therapy can induce hypercapnic respiratory failure in patients with respiratory diseases and musculoskeletal diseases in upper airways. Sudden cessation of oxygen supplementation in these patients can further lead to rebound hypoxaemia. In patients with mild or moderate strokes, hyperoxaemia may cause absorption atelectasis or myocardial infarction. Oxygen content should be monitored following the administration to verify therapeutic benefit.
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image 40% Oxygen/Nitrogen Mix Gas 400 mL/1L Respiratory (inhalation) NexAir LLC 2020-04-09 Not applicable US Air Gas 20.9 L/100L Respiratory (inhalation) Indianapolis Welding Supply, Inc 1972-01-01 2013-04-12 US Air Gas 195 mL/1000mL Respiratory (inhalation) Industrial Gas Distributors Inc 1987-04-01 2015-12-29 US Air Gas 21 L/1L Respiratory (inhalation) Lampton Welding Supply Company, Inc 2018-04-18 Not applicable US Air Gas 210 mL/1L Respiratory (inhalation) Airgas Mid South, Inc. 1997-11-06 2010-03-02 US - Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image O2hundred Gas 99.9 mg/100mg Topical Tov Innovation Co.Ltd 2023-06-05 Not applicable US Oxygen Gas 992 mL/1L Respiratory (inhalation) Arkansas Welding & Industrial Supply 2001-10-20 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Alnox Gas Oxygen (50 %) + Nitrous oxide (50 %) Gas Respiratory (inhalation) Air Liquide Canada Inc. 1995-12-31 Not applicable Canada Carbogen Oxygen (50 %) + Carbon dioxide (50 %) Gas Respiratory (inhalation) Messer Canada Inc. 1995-12-31 Not applicable Canada Carbon Dioxide 1% W Oxygen Oxygen (93 %) + Carbon dioxide (7 %) Gas Respiratory (inhalation) Liquid Carbonic Inc. 1990-12-31 1998-06-09 Canada Carbon Dioxide 12.1% W Oxygen Oxygen (77 %) + Carbon dioxide (23 %) Gas Respiratory (inhalation) Praxair, Inc. 1990-12-31 Not applicable Canada Carbon Dioxide 23.1% W Oxygen Oxygen (50 %) + Carbon dioxide (50 %) Gas Respiratory (inhalation) Praxair, Inc. 1990-12-31 Not applicable Canada - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Air Oxygen (23 L/100L) + Nitrogen (77 L/100L) Gas Respiratory (inhalation) Air Liquide Canada Inc. 1960-01-01 Not applicable US Air Oxygen (99 L/100L) + Nitrogen (99 L/100L) Gas Respiratory (inhalation) Air Liquide Canada Inc. 1960-01-01 2010-06-15 US Air Oxygen (20.9 L/100L) Gas Respiratory (inhalation) Indianapolis Welding Supply, Inc 1972-01-01 2013-04-12 US Air Oxygen (195 mL/1000mL) Gas Respiratory (inhalation) Industrial Gas Distributors Inc 1987-04-01 2015-12-29 US Air Oxygen (210 mL/1L) Gas Respiratory (inhalation) Airgas Mid South, Inc. 1997-11-06 2010-03-02 US
Categories
- ATC Codes
- V03AN01 — Oxygen
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of inorganic compounds known as other non-metal oxides. These are inorganic compounds containing an oxygen atom of an oxidation state of -2, in which the heaviest atom bonded to the oxygen belongs to the class of 'other non-metals'.
- Kingdom
- Inorganic compounds
- Super Class
- Homogeneous non-metal compounds
- Class
- Other non-metal organides
- Sub Class
- Other non-metal oxides
- Direct Parent
- Other non-metal oxides
- Alternative Parents
- Inorganic oxides
- Substituents
- Inorganic oxide / Other non-metal oxide
- Molecular Framework
- Not Available
- External Descriptors
- diatomic oxygen, elemental molecule (CHEBI:15379) / a non-metabolic compound (OXYGEN-MOLECULE)
- Affected organisms
- Humans and other mammals
Chemical Identifiers
- UNII
- S88TT14065
- CAS number
- 7782-44-7
- InChI Key
- MYMOFIZGZYHOMD-UHFFFAOYSA-N
- InChI
- InChI=1S/O2/c1-2
- IUPAC Name
- dioxygen
- SMILES
- O=O
References
- General References
- Heyboer M 3rd, Milovanova TN, Wojcik S, Grant W, Chin M, Hardy KR, Lambert DS, Logue C, Thom SR: CD34+/CD45-dim stem cell mobilization by hyperbaric oxygen - changes with oxygen dosage. Stem Cell Res. 2014 May;12(3):638-45. doi: 10.1016/j.scr.2014.02.005. Epub 2014 Feb 28. [Article]
- Prabhakar NR: Oxygen sensing by the carotid body chemoreceptors. J Appl Physiol (1985). 2000 Jun;88(6):2287-95. [Article]
- Feng Z, Liu J, Ju R: Hyperbaric oxygen treatment promotes neural stem cell proliferation in the subventricular zone of neonatal rats with hypoxic-ischemic brain damage. Neural Regen Res. 2013 May 5;8(13):1220-7. doi: 10.3969/j.issn.1673-5374.2013.13.007. [Article]
- Lopez-Barneo J, Gonzalez-Rodriguez P, Gao L, Fernandez-Aguera MC, Pardal R, Ortega-Saenz P: Oxygen sensing by the carotid body: mechanisms and role in adaptation to hypoxia. Am J Physiol Cell Physiol. 2016 Apr 15;310(8):C629-42. doi: 10.1152/ajpcell.00265.2015. Epub 2016 Jan 13. [Article]
- Liu W, Khatibi N, Sridharan A, Zhang JH: Application of medical gases in the field of neurobiology. Med Gas Res. 2011 Jun 27;1(1):13. doi: 10.1186/2045-9912-1-13. [Article]
- British Thoracic Society: Guideline for emergency oxygen use in adult patients [Link]
- Airgas SDS [Link]
- Linde SDS [Link]
- External Links
- Human Metabolome Database
- HMDB0001377
- KEGG Drug
- D00003
- KEGG Compound
- C00007
- PubChem Compound
- 977
- PubChem Substance
- 310265054
- ChemSpider
- 952
- 7806
- ChEBI
- 27140
- ChEMBL
- CHEMBL1234886
- PharmGKB
- PA450744
- PDBe Ligand
- OXY
- Drugs.com
- Drugs.com Drug Page
- Wikipedia
- Oxygen
- PDB Entries
- 1a4f / 1a6m / 1ash / 1b86 / 1dcc / 1dp6 / 1dz8 / 1e5d / 1f65 / 1faw … show 483 more
- MSDS
- Download (177 KB)
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count 4 Active Not Recruiting Basic Science Anesthesia therapy 1 4 Active Not Recruiting Prevention Coronavirus Disease 2019 (COVID‑19) / Hypoxemic Respiratory Failure / Oxygen Toxicity 1 4 Completed Basic Science Hyperoxia / Hypoxia, Brain / Neurobehavioral Manifestations 1 4 Completed Diagnostic Cancer / Pain 1 4 Completed Prevention Fraction of Inspired Oxygen / Hyperoxemia / Hyperoxia / Oxygen Reserve Index 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Gas Respiratory (inhalation) 195 mL/1000mL Gas Respiratory (inhalation) 20.9 L/100L Gas Respiratory (inhalation) 21 L/1L Gas Respiratory (inhalation) 235 mL/1L Gas Respiratory (inhalation) 20 % Gas Respiratory (inhalation) 100 % v/v Gas Respiratory (inhalation) 21.75 % Gas Respiratory (inhalation) 950 mL/1L Gas Respiratory (inhalation) 50 mL/1L Gas Respiratory (inhalation) 80 L/100L Gas Respiratory (inhalation) 90 L/100L Gas Respiratory (inhalation) 96 L/100L Gas Respiratory (inhalation) 40 L/100L Gas Respiratory (inhalation) 95 L/100L Gas Respiratory (inhalation) 20 L/100L Gas Respiratory (inhalation) 25 L/100L Gas Respiratory (inhalation) 30 L/100L Gas Respiratory (inhalation) Gas Respiratory (inhalation) 21 L/100L Gas Respiratory (inhalation) 23 L/100L Gas Respiratory (inhalation) 21 % Gas Topical 99.9 mg/100mg Gas Respiratory (inhalation) 0.47 L/0.47L Gas Respiratory (inhalation) 100 % Gas Respiratory (inhalation) 11 L/11L Gas Respiratory (inhalation) 12 L/12L Gas Respiratory (inhalation) 4 L/4L Gas Respiratory (inhalation) 20 L/20L Gas Respiratory (inhalation) 0.66 L/0.66L Gas Respiratory (inhalation) 0.95 L/0.95L Gas Respiratory (inhalation) Gas Respiratory (inhalation) 30 L/30L Gas Respiratory (inhalation) 1500 L/1500L Gas Respiratory (inhalation) 5000 L/5000L Gas Respiratory (inhalation) 18 L/18L Gas Respiratory (inhalation) 23.6 L/23.6L Gas Respiratory (inhalation) 33 L/33L Gas Respiratory (inhalation) 8.75 L/8.75L Gas Respiratory (inhalation) 0.5 L/0.5L Gas Respiratory (inhalation) 1 L/L Gas Respiratory (inhalation) 10 L/10L Gas Respiratory (inhalation) 14 L/14L Gas Respiratory (inhalation) 2 L/2L Gas Respiratory (inhalation) 27 L/27L Gas Respiratory (inhalation) 3 L/3L Gas Respiratory (inhalation) 40 L/40L Gas Respiratory (inhalation) 5 L/5L Gas Respiratory (inhalation) 50 L/50L Gas Respiratory (inhalation) 7 L/7L Gas Respiratory (inhalation) 10 L Gas Respiratory (inhalation) 1000 L Gas Respiratory (inhalation) 10000 L Gas Respiratory (inhalation) 12000 L Gas Respiratory (inhalation) 1500 L Gas Respiratory (inhalation) 15000 L Gas Respiratory (inhalation) 160 L Gas Respiratory (inhalation) 180 L Gas Respiratory (inhalation) 2000 L Gas Respiratory (inhalation) 20000 L Gas Respiratory (inhalation) 21 L Gas Respiratory (inhalation) 230 L Gas Respiratory (inhalation) 2500 L Gas Respiratory (inhalation) 3000 L Gas Respiratory (inhalation) 30000 L Gas Respiratory (inhalation) 31 L Gas Respiratory (inhalation) 32 L Gas Respiratory (inhalation) 36 L Gas Respiratory (inhalation) 4000 L Gas Respiratory (inhalation) 40000 L Gas Respiratory (inhalation) 41 L Gas Respiratory (inhalation) 46 L Gas Respiratory (inhalation) 5000 L Gas Respiratory (inhalation) 6000 L Gas Respiratory (inhalation) 60 L/60L Gas Respiratory (inhalation) 0.74 L/0.74L Gas Respiratory (inhalation) 1.34 L/1.34L Gas Respiratory (inhalation) 15 L/15L Gas Respiratory (inhalation) 17 L/17L Gas Respiratory (inhalation) 24 L/24L Gas Respiratory (inhalation) 25.5 L/25.5L Gas Respiratory (inhalation) 28 L/28L Gas Respiratory (inhalation) 90 % Gas Respiratory (inhalation) 93 % Gas Respiratory (inhalation) 93 % v/v Gas Respiratory (inhalation) 9300000 % v/v Gas Respiratory (inhalation) 96 % Gas Respiratory (inhalation) 99 % v/v Gas Respiratory (inhalation) 99 v/v Gas Respiratory (inhalation) 9900000 v/v Gas Respiratory (inhalation) 9900000 % v/v Gas Respiratory (inhalation) 3.25 m3 Gas Respiratory (inhalation) 6.5 m3 Gas Respiratory (inhalation) 99 % Gas Respiratory (inhalation) 94.9722 % v/v Gas Respiratory (inhalation) 98 % v/v Gas Respiratory (inhalation) 7.5 L/7.5L Gas Gas 95 % Gas Cutaneous; Respiratory (inhalation) 992 mL/1L Gas Nasal 1 L/1L Gas Nasal 210 mL/1L Gas Nasal 99 L/100L Gas Nasal; Respiratory (inhalation) 1 L/1L Gas Nasal; Respiratory (inhalation) 995 mL/1L Gas Respiratory (inhalation) .99 L/1L Gas Respiratory (inhalation) .995 L/1L Gas Respiratory (inhalation) 100 L/99L Gas Respiratory (inhalation) 1000 mL/1L Gas Respiratory (inhalation) 210 mL/1L Gas Respiratory (inhalation) 900 mL/1L Gas Respiratory (inhalation) 93 mL/1L Gas Respiratory (inhalation) 930 mL/1L Gas Respiratory (inhalation) 99 L/99L Gas Respiratory (inhalation) 99 mL/1L Gas Respiratory (inhalation) 99 mL/100mL Gas Respiratory (inhalation) 99 L/100L Gas Respiratory (inhalation) 99 L/1L Gas Respiratory (inhalation) 99.1 L/1L Gas Respiratory (inhalation) 99.4 L/100L Gas Respiratory (inhalation) 99.5 L/100L Gas Respiratory (inhalation) 99.5 L/1L Gas Respiratory (inhalation) 99.6 L/1L Gas Respiratory (inhalation) 99.6 L/100L Gas Respiratory (inhalation) 99.6 % Gas Respiratory (inhalation) 99.8 L/100L Gas Respiratory (inhalation) 99.8 L/1L Gas Respiratory (inhalation) 99.9 L/100L Gas Respiratory (inhalation) 99.9 mL/1L Gas Respiratory (inhalation) 99.9 L/1L Gas Respiratory (inhalation) 990 mL/1L Gas Respiratory (inhalation) 990 L/1L Gas Respiratory (inhalation) 990 1/1L Gas Respiratory (inhalation) 991 mL/1L Gas Respiratory (inhalation) 992 1/1L Gas Respiratory (inhalation) 992 mL/1L Gas Respiratory (inhalation) 992 L/1000L Gas Respiratory (inhalation) 992 mL/1000mL Gas Respiratory (inhalation) 995 mL/100L Gas Respiratory (inhalation) 995 L/1L Gas Respiratory (inhalation) 995 mL/1L Gas Respiratory (inhalation) 996 mL/1L Gas Respiratory (inhalation) 997 mL/1L Gas Respiratory (inhalation) 998 mL/1L Gas Respiratory (inhalation) 999 mL/1L Gas Respiratory (inhalation) 999 L/1000L Liquid Respiratory (inhalation) 1.13835106 kg/1L Liquid Respiratory (inhalation) 1000 g/1L Liquid Respiratory (inhalation) 210 mg/1kg Liquid Respiratory (inhalation) 99 1/100L Liquid Respiratory (inhalation) 99 L/100L Liquid Respiratory (inhalation) 992 L/1000L Liquid Respiratory (inhalation) 995 mL/1L Liquid Respiratory (inhalation) 999 L/1000L Gas Respiratory (inhalation) 99.0 % Gas Respiratory (inhalation) 99.95 % Gas Respiratory (inhalation) 992 mL/100mL Gas Respiratory (inhalation) 0.995 mL/1L Gas Respiratory (inhalation) 200 mL/1L Gas Respiratory (inhalation) 0.99 kg/1kg Gas Respiratory (inhalation) 11321 L/11321L Gas Respiratory (inhalation) 196 L/196L Gas Respiratory (inhalation) 240 L/240L Gas Respiratory (inhalation) 396 L/396L Gas Respiratory (inhalation) 659 L/659L Gas Respiratory (inhalation) 1567 L/1567L Gas Respiratory (inhalation) 6931 L/6931L Gas Respiratory (inhalation) 3453 L/3453L Gas Respiratory (inhalation) 8688 L/8688L Gas Respiratory (inhalation) 99.9 % Gas Respiratory (inhalation) 99.99 % Gas Nasal; Oral 100 % Gas Respiratory (inhalation) 99.5 % Gas Respiratory (inhalation) 250 mL/1L Gas Respiratory (inhalation) 300 mL/1L Gas Respiratory (inhalation) 330 mL/1L Gas Respiratory (inhalation) 400 mL/1L Gas Respiratory (inhalation) 500 mL/1L Gas Respiratory (inhalation) 600 mL/1L Gas Respiratory (inhalation) 800 mL/1L Gas; liquid Respiratory (inhalation) 99.5 % Gas Respiratory (inhalation) 99.2 % Liquid Respiratory (inhalation) 1 L/1L Gas Respiratory (inhalation) 1 L/1L Gas Respiratory (inhalation) 100 mL/1L Gas Respiratory (inhalation) 120 mL/1L Gas Respiratory (inhalation) 150 mL/1L Gas Respiratory (inhalation) 260 mL/1L Gas Respiratory (inhalation) 380 mL/1L Gas Respiratory (inhalation) 520 mL/1L Gas Respiratory (inhalation) 750 mL/1L Gas Respiratory (inhalation) 97 mL/1L - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Gas
- Experimental Properties
Property Value Source melting point (°C) -218.4 Airgas SDS boiling point (°C) -183 Airgas SDS water solubility 39mg/L Linde SDS logP 0.65 SDS - Predicted Properties
Property Value Source logP -0.28 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 34.14 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 2.89 m3·mol-1 Chemaxon Polarizability 1.53 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 107.69548 predictedDeepCCS 1.0 (2019) [M+H]+ 109.419876 predictedDeepCCS 1.0 (2019) [M+Na]+ 116.16852 predictedDeepCCS 1.0 (2019)
Targets
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- Actions
- AgonistActivator
- General Function
- Iron ion binding
- Specific Function
- Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Subunits 1-3 form the functional core of the enzyme complex. CO I is the catalytic su...
- Gene Name
- MT-CO1
- Uniprot ID
- P00395
- Uniprot Name
- Cytochrome c oxidase subunit 1
- Molecular Weight
- 57040.91 Da
References
- Wilson MT, Antonini G, Malatesta F, Sarti P, Brunori M: Probing the oxygen binding site of cytochrome c oxidase by cyanide. J Biol Chem. 1994 Sep 30;269(39):24114-9. [Article]
- Thomson AJ, Greenwood C, Gadsby PM, Peterson J, Eglinton DG, Hill BC, Nicholls P: The structure of the cytochrome a3-CuB site of mammalian cytochrome c oxidase as probed by MCD and EPR spectroscopy. J Inorg Biochem. 1985 Mar-Apr;23(3-4):187-97. [Article]
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- Actions
- AgonistActivator
- General Function
- Voltage-gated proton channel activity
- Specific Function
- NOH-1S is a voltage-gated proton channel that mediates the H(+) currents of resting phagocytes and other tissues. It participates in the regulation of cellular pH and is blocked by zinc. NOH-1L is ...
- Gene Name
- NOX1
- Uniprot ID
- Q9Y5S8
- Uniprot Name
- NADPH oxidase 1
- Molecular Weight
- 64870.455 Da
References
Carriers
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- Actions
- Binder
- Curator comments
- Binding increases the affinity of other binding sites for oxygen.
- General Function
- Oxygen transporter activity
- Specific Function
- Involved in oxygen transport from the lung to the various peripheral tissues.LVV-hemorphin-7 potentiates the activity of bradykinin, causing a decrease in blood pressure.Spinorphin: functions as an...
- Gene Name
- HBB
- Uniprot ID
- P68871
- Uniprot Name
- Hemoglobin subunit beta
- Molecular Weight
- 15998.34 Da
References
- Hamilton HB, Iuchi I, Miyaji T, Shibata S: Hemoglobin Hiroshima (beta-143 histidine--aspartic acid): a newly identified fast moving beta chain variant associated with increased oxygen affinity and compensatory erythremia. J Clin Invest. 1969 Mar;48(3):525-35. [Article]
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- Actions
- Binder
- General Function
- Oxygen transporter activity
- Specific Function
- Involved in oxygen transport from the lung to the various peripheral tissues.
- Gene Name
- HBA1
- Uniprot ID
- P69905
- Uniprot Name
- Hemoglobin subunit alpha
- Molecular Weight
- 15257.405 Da
References
- Miyashita H, Hashimoto K, Mohri H, Ohokubo T, Harano T, Harano K, Imai K: Hb Kanagawa [alpha 40(C5)Lys----Met]: a new alpha chain variant with an increased oxygen affinity. Hemoglobin. 1992;16(1-2):1-10. [Article]
Drug created at September 30, 2015 16:55 / Updated at February 20, 2024 23:55